Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.

Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.

Item
http://www.wikidata.org/entity/Q39608912
Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cellsSystematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells.Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia.CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice.The evolution of clinical trials for infant acute lymphoblastic leukemia.Comparison of in vitro antileukemic activity of obatoclax and ABT-737.Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells.Dysregulation of BCL-2 family proteins by leukemia fusion genes.Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy.Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery.
P2860

Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.

Item
http://www.wikidata.org/entity/Q39608912
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@en
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@nl
type
label
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@en
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@nl
prefLabel
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@en
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Cytotoxicity, drug combinabili ...... cells with MLL rearrangement.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921